HIRTH-DIETRICH, Claudia,SANDNER, Peter,STASCH, Johannes-Peter,KNORR, Andreas,VON DEGENFELD, Georges,HAHN, Michael,FOLLMANN, Markus
申请号：
HUE11722786
公开号：
HUE025162T2
申请日:
2011.05.24
申请国别(地区):
HU
年份:
2016
代理人:
摘要：
The use of sGC stimulators, sGC activators alone, or in combination with PDE5 inhibitors for the prevention and treatment of fibrotic diseases, such as systemic sclerosis, scleroderma, and the concomitant fibrosis of internal organs.
